Mayo Clinic Labs CEO explains how healthcare's data revolution reshapes clinical diagnostics and accelerates medical research.

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

A large Mayo Clinic study shows that current guidelines fail to detect nearly 90% of people with familial ...

Cholesterol meds—taking by millions of Americans every day—often come with a lifelong prescription, adding out-of-pocket ...

Two years ago, the UK became the first country to approve Casgevy, a Crispr-based therapy for the blood disorders sickle cell disease and β-thalassaemia. This year saw the world’s first personalised ...

Genetic-medicines-focused Scribe Therapeutics is racing toward the clinic on the heels of a preclinical data drop for three programs, all of which were able to reduce cardiovascular risk factors in ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common illnesses. So far, only 15 people have received the treatment. But, if all ...